Company News-Guangzhou Raytec Biotechnology Co., Ltd

Formally entering the era of "double engines" driving | The Wet Bio-amnion of Raytec Biology was approved for listing

On July 1, 2024, marking the 103rd anniversary of the founding of the Communist Party of China, Raytec Biotech has achieved new breakthroughs in its solutions for ocular surface regeneration and repair. The company's independently developed Class III implantable medical device product, "Wet-state Bio-amnion," officially obtained the medical device registration certificate in Sichuan.

Raytec Biotechnology was honored to be listed in the Top 50 Biotechnology Innovation Enterprises in the Guangdong-Hong Kong-Macao Greater Bay Area for the 6th consecutive year, and also recognized as one of the Top 50 Leading Enterprises in Guangzhou's IP

On the afternoon of December 28, 2023, the 6th Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology Innovation Enterprise Top 50 Awards Ceremony was grandly held in Nansha, Guangzhou. Guangzhou Raytec Biotechnology Co., Ltd., with its outstanding performance in technological innovation, product advantages, industrialization capabilities, talent team, industry status, and social responsibility, was honored to be listed in the Top 50 Biotechnology Innovation Enterprises in the Guangdong-Hong K

07/24
2023
Epicon A® The National Listing Conference of Scleroscopes CCCRS2023 was successfully held11 top national eye watch experts Three fantastic and unparalleled Epicon A® Theme report on scleral endoscopy 400+ophthalmic colleagues stopped at the scene to observe Using a mirror as a boat, helping the eyes clear and bright
07/20
2023
The signing ceremony for the joint venture between Raytec Biotechnology and Capricornia Contact Lens Pty Ltd in Chengdu, titled "China Australia Co construction, Bright Forward", was successfully heldOn July 19th, the signing ceremony for the joint venture between Guangzhou Raytec Biotechnology Co., Ltd. and Capricornia Contact Lens Pty Ltd in Australia was successfully held in Wenjiang, Chengdu. Dr. Lin Yongliang, founder/chairman of Raytec Biotechnology, Xu Hao, co-founder/general manager, and Tony Capitano, chairman and general manager of Capricornia, Australia, attended the signing ceremony.
06/23
2023
Great news| Epicon A® Scleroscope officially approved for market, filling the gap in clinical treatment of ophthalmology in ChinaOn June 20, 2023, Guangzhou Raytec Biotechnology Co., Ltd. announced that the original Australian scleral lens: Epicon A ® Obtained import registration approval from the National Medical Products Administration (NMPA) (National Medical Products Administration [20233160254]) and officially launched in China. It is the first and currently the only domestically approved scleral lens in China.
04/17
2023
Raytec Biotechnology, Together with Sincerity, Work Together for Prosperity | The Perfect Closing of the 22nd COOCOn April 14-16, 2023, COOC2022 successfully concluded at the Shanghai International Procurement Exhibition Center. Guangzhou Raytec Biotechnology Co., Ltd. made its grand debut at booth C28, showcasing exclusive products from across the country and the first ophthalmic products. During the exhibition, there was a surge of people, and Raytec Biotechnology received unanimous praise from the attendees for its exclusive product advantages, excellent professional standards, and attentive service qual
04/10
2023
Raytec Biotechnology completes Series A+financing to accelerate the commercialization of innovative ophthalmic devices and regenerative medicine productsIn early March 2023, Guangzhou Raytec Biotechnology Co., Ltd. (hereinafter referred to as "Ruitai Biotechnology") completed a Series A+financing of nearly 100 million yuan. This round of financing is led by Songhe Capital, followed by Zhongda Venture Capital and well-known industrial capital. The existing shareholder Huimei Capital continues to increase its investment.
09/21
2020
Raytec Biotechnology Chengdu Medical City Project SignedOn September 16th, the Chengdu Medical City (Science and Technology Park) held a concentrated signing ceremony for the 2020 Chengdu Medical City project in Wenjiang District. Li Yi, Deputy Secretary of the Wenjiang District Committee, Lu Hongxing, Deputy District Mayor of the District Government, and Qin Baoping, Deputy District Level Leader, attended the signing ceremony.